|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.70 USD | -0.54% |
|
-8.36% | +20.59% |
| 08-07 | DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MT |
| 08-06 | Barclays Adjusts Price Target on CVS Health to $108 From $106 | MT |
| Market Cap | 122B 106B 98.87B 90.7B 171B 11,649B 173B 1,160B 455B 5,839B 460B 450B 19,302B | P/E 2026 * |
14.3x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 175B 152B 142B 130B 244B 16,674B 248B 1,660B 652B 8,357B 658B 643B 27,629B | EV / Sales 2026 * |
0.42x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.78% | Yield 2027 * | 2.86% |
Last Transcript: CVS Health Corporation
| 1 day | -0.54% | ||
| 1 week | -8.36% | ||
| Current month | -8.36% | ||
| 1 month | -8.27% | ||
| 3 months | +9.55% | ||
| 6 months | +22.14% | ||
| Current year | +20.59% |
| 1 week | 93.5 |  | 105.69 |
| 1 month | 93.5 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 64.32 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -8.36% | +50.52% | +29.48% | 122B | |
| +1.09% | +2.68% | +10.72% | +51.65% | 89.49B | |
| +0.81% | +5.71% | +11.31% | +66.88% | 30.64B | |
| -0.06% | +2.29% | +36.77% | +74.47% | 26.31B | |
| -2.13% | -0.26% | -11.21% | -16.82% | 21.85B | |
| +2.14% | +2.88% | +60.40% | +246.27% | 21.11B | |
| +0.41% | -5.40% | +2.76% | -10.57% | 12.88B | |
| +1.72% | -23.46% | +43.92% | +63.09% | 11.72B | |
| -0.19% | -2.33% | -15.33% | +84.03% | 10.97B | |
| +2.25% | +3.03% | +2.67% | +26.96% | 10.51B | |
| Average | +0.55% | -2.32% | +19.25% | +61.54% | 35.79B | |
| Weighted average by Cap. | +0.28% | -2.32% | +27.65% | +52.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 414B 358B 334B 307B 577B 39,398B 586B 3,923B 1,540B 19,747B 1,555B 1,520B 65,283B | 428B 371B 346B 317B 597B 40,774B 607B 4,060B 1,594B 20,437B 1,609B 1,574B 67,563B |
| Net income | 8.59B 7.43B 6.94B 6.36B 11.97B 817B 12.16B 81.4B 31.95B 410B 32.25B 31.55B 1,354B | 9.02B 7.8B 7.28B 6.68B 12.57B 858B 12.77B 85.46B 33.54B 430B 33.86B 33.12B 1,422B |
| Net Debt | 52.8B 45.67B 42.65B 39.12B 73.59B 5,025B 74.76B 500B 196B 2,519B 198B 194B 8,326B | 49.44B 42.77B 39.94B 36.64B 68.91B 4,705B 70B 469B 184B 2,359B 186B 182B 7,797B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$95.70 | -0.54% | 12,400,536 |
| 26-08-06 | US$96.22 | -2.93% | 10,583,035 |
| 26-08-05 | US$99.12 | -5.08% | 18,514,644 |
| 26-08-04 | US$104.42 | -0.90% | 7,229,227 |
| 26-08-03 | US$105.37 | +0.90% | 5,377,252 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
